Endocrinology 2014;155:128090
Pedersen C, Lefevre S, Peters V, Patterson M, Ghatei MA, Morgan LM, et al
In October 2023, A Research Study to See How Semaglutide Works Compared to Placebo in People with Type 2 Diabetes and Chronic Kidney Disease (FLOW) trial assessing the effect of semaglutide versus placebo on the progression of renal impairment in people with T2DM and chronic kidney disease was stopped prematurely due to results of an interim analysis showing significant efficacy of semaglutide with full results due to be released in the first half of 2024 [39]
For scars that remain, such as indentations or raised marks, dermatologists often recommend treatments like lasers, microneedling, or chemical peels after completing Accutane therapy
But optimal ranges can vary by the individual and by the routes that you're taking
Lifestyle intervention in patients with obesity and type 2 diabetes